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Freeze-drying or lyophilization is a multi-stage operation of ef-
fectively drying a material while preserving its biological
properties. The material is subject to being frozen and subli-
mated under vacuum upon heating. Lyophillized products are
more stable, easily transported and quickly reconstituted. A
benefit of low-temperature operation envisages its applica-
tions in pharmaceuticals for heat-sensitive components
including vaccine and biological products.To date, analyses of
the freeze-drying process have been changed from physical
aspects of freezing and sublimation to a more sophisticated
examination of the effects of the process on the chemical struc-
tures and the biological properties of the products themselves
[1]. In this study, development of some lyophilized products
was demonstrated with a focus on process optimization to
minimize a cycle time and increase productivity in commer-
cial production. Thermal behaviors of the product were
examined by Differential Scanning Calorimetry under freezing
and heating conditions to design appropriate freeze-drying
cycles. Experimentation was performed with a laboratory ly-
ophilizer to verify critical process parameters including freezing
rate, drying temperature, drying time and pressure manipu-
lation. Finally, a success of process transfer from the laboratory
bench to more diversified industrial operations was an ac-
complishment of basic knowledge and understanding of the
equipment operation, environmental concerns and sterile han-
dling of the bulk product.
R E F E R E N C E
[1] Rey L, May JC. Freeze-drying/lyophilization of pharmaceutical
and biological products. 2nd ed. NewYork: Marcel Dekker.;
2004.
* E-mail address: krisanin.chansanroj@pharmanueva.com.
Peer review under responsibility of Shenyang Pharmaceutical University.
http://dx.doi.org/10.1016/j.ajps.2015.10.025
1818-0876/© 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of Shenyang Pharmaceutical University. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
a s i an j o u rna l o f p h a rma c eu t i c a l s c i e n c e s 1 1 ( 2 0 1 6 ) 3 9
Available online at www.sciencedirect.com
journal homepage: www.elsevier.com/ locate /a jps
HOSTED BY
ScienceDirect
